Profound skeletal muscle depletion of alpha-dystroglycan in Walker-Warburg syndrome.
Walker-Warburg syndrome (WWS) is an autosomal recessive disorder characterized by the combined involvement of the central nervous and skeletal muscle systems. Although the molecular basis of WWS remains unknown, defects in the muscle fibre basal lamina are characteristic of other forms of congenital muscular dystrophy (CMD). In agreement with this, some forms of CMD, due to glycosyltransferase defects, display a reduction in the immunolabelling of alpha-dystroglycan, whilst beta-dystroglycan labelling appears normal. Here we describe an almost complete absence of alpha-dystroglycan using both immunohistochemistry and immunoblotting in two patients with WWS. In addition, there was a mild reduction of laminin-alpha 2. In contrast, immunohistochemical labelling of perlecan and collagen VI was normal. Linkage analysis excluded the recently identified POMT1 locus, responsible for a proportion of WWS cases. These results confirm that WWS is a genetically heterogeneous condition and suggest that disruption of the alpha-dystroglycan/laminin-alpha 2 axis in the basal lamina may play a role in the degeneration of muscle fibres in WWS-also in cases not due to POMT1 defects.
Jiménez-Mallebrera
Cecilia
C
Neuromuscular Unit, Imperial College School of Medicine, Hammersmith Hospital, London, UK. c.jimenez@ic.ac.uk
Torelli
Silvia
S
Brown
Susan C
SC
Feng
Lucy
L
Brockington
Martin
M
Sewry
Caroline A
CA
Beltrán-Valero De Bernabé
Daniel
D
Muntoni
Francesco
F
D001485:Basement Membrane / Q000378:metabolism / Q000473:pathology; D015153:Blotting, Western; D002493:Central Nervous System Diseases / Q000150:complications* / Q000235:genetics / Q000378:metabolism*; D002675:Child, Preschool; D024142:Collagen Type VI / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D049030:Dystroglycans; D005260:Female; D008040:Genetic Linkage / Q000235:genetics; D006031:Glycosylation; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D007797:Laminin / Q000172:deficiency; D008297:Male; D008364:Mannosyltransferases / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D018485:Muscle Fibers, Skeletal / Q000378:metabolism / Q000473:pathology; D009136:Muscular Dystrophies / Q000150:complications* / Q000235:genetics / Q000378:metabolism*; D011494:Protein Kinases / Q000235:genetics; D029702:Schizosaccharomyces pombe Proteins; D013577:Syndrome
D024142:Collagen Type VI; D003598:Cytoskeletal Proteins; C483081:DAG1 protein, human; D019812:Heparan Sulfate Proteoglycans; D007797:Laminin; D008562:Membrane Glycoproteins; D029702:Schizosaccharomyces pombe Proteins; C102645:laminin alpha 2; C071927:perlecan; D049030:Dystroglycans; D008364:Mannosyltransferases; C082696:protein O-mannosyltransferase; D011494:Protein Kinases; C112212:Pom1 protein, S pombe